Cargando…
Effect of gold nanoparticles treatment on the testosterone-induced benign prostatic hyperplasia in rats
Background: Gold nanoparticles (AuNps) are promising agents for prostate cancer therapy. Herein, the in vivo effects of 20 and 50 nm sized AuNps on experimentally induced benign prostatic hyperplasia (BPH) was examined. Materials and methods: Adult male rats were divided into four groups (n=6–8 each...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507074/ https://www.ncbi.nlm.nih.gov/pubmed/31118628 http://dx.doi.org/10.2147/IJN.S202645 |
_version_ | 1783416957479944192 |
---|---|
author | Al-Trad, Bahaa Aljabali, Alaa Al Zoubi, Mazhar Shehab, Malek Omari, Sahar |
author_facet | Al-Trad, Bahaa Aljabali, Alaa Al Zoubi, Mazhar Shehab, Malek Omari, Sahar |
author_sort | Al-Trad, Bahaa |
collection | PubMed |
description | Background: Gold nanoparticles (AuNps) are promising agents for prostate cancer therapy. Herein, the in vivo effects of 20 and 50 nm sized AuNps on experimentally induced benign prostatic hyperplasia (BPH) was examined. Materials and methods: Adult male rats were divided into four groups (n=6–8 each). A negative control group and three groups were injected daily with testosterone (3 mg/kg/subcutaneously) to induce BPH. Animals receiving testosterone were randomized to untreated BPH group and two BPH groups which were treated intraperitoneally with 20 and 50 nm AuNps (5 mg/kg/daily) in addition to testosterone. After three weeks, histopathological changes and serum levels of testosterone and dihydrotestosterone (DHT) were analyzed. In addition, the prostate tissue levels of transforming growth factor-β(1) (TGF-β(1)), vascular endothelial growth factor-a (VEGF-A) and interleukin-6 (IL-6) were measured using ELISA. Results: There were significant increases in the prostate weight/body weight ratio, serum testosterone and DHT and in the prostate tissue content of TGF-β(1), IL-6 and VEGF-A in the untreated BPH group. histological examination showed morphological abnormalities with more proliferation in the glandular epithelial and stromal area and with abundant epithelial papillary folds in the BPH group. Simultaneous administration of 50 nm AuNps with testosterone tended to increase the prostate weight/body weight ratio and increase the tissue level of IL-6 in compared to the BPH group. Conversely, treatment with 20 nm AuNps significantly reduced the elevated tissue content of TGF-β(1), IL-6, and VEGF-A. Histopathological examination also showed that 20 nm but not the 50 nm AuNps administration ameliorates testosterone-induced prostatic hyperplasia. Conclusions: In experimentally induced BPH, AuNps can inhibit the progression of BPH in a size-dependent manner. while 20 nm AuNps ameliorate BPH by its inhibitory effects on the prostatic cell proliferation, inflammation and angiogenesis, the 50 nm AuNps could potentially exacerbate the development of BPH in rats, mainly through enhancing the inflammatory process. |
format | Online Article Text |
id | pubmed-6507074 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-65070742019-05-22 Effect of gold nanoparticles treatment on the testosterone-induced benign prostatic hyperplasia in rats Al-Trad, Bahaa Aljabali, Alaa Al Zoubi, Mazhar Shehab, Malek Omari, Sahar Int J Nanomedicine Original Research Background: Gold nanoparticles (AuNps) are promising agents for prostate cancer therapy. Herein, the in vivo effects of 20 and 50 nm sized AuNps on experimentally induced benign prostatic hyperplasia (BPH) was examined. Materials and methods: Adult male rats were divided into four groups (n=6–8 each). A negative control group and three groups were injected daily with testosterone (3 mg/kg/subcutaneously) to induce BPH. Animals receiving testosterone were randomized to untreated BPH group and two BPH groups which were treated intraperitoneally with 20 and 50 nm AuNps (5 mg/kg/daily) in addition to testosterone. After three weeks, histopathological changes and serum levels of testosterone and dihydrotestosterone (DHT) were analyzed. In addition, the prostate tissue levels of transforming growth factor-β(1) (TGF-β(1)), vascular endothelial growth factor-a (VEGF-A) and interleukin-6 (IL-6) were measured using ELISA. Results: There were significant increases in the prostate weight/body weight ratio, serum testosterone and DHT and in the prostate tissue content of TGF-β(1), IL-6 and VEGF-A in the untreated BPH group. histological examination showed morphological abnormalities with more proliferation in the glandular epithelial and stromal area and with abundant epithelial papillary folds in the BPH group. Simultaneous administration of 50 nm AuNps with testosterone tended to increase the prostate weight/body weight ratio and increase the tissue level of IL-6 in compared to the BPH group. Conversely, treatment with 20 nm AuNps significantly reduced the elevated tissue content of TGF-β(1), IL-6, and VEGF-A. Histopathological examination also showed that 20 nm but not the 50 nm AuNps administration ameliorates testosterone-induced prostatic hyperplasia. Conclusions: In experimentally induced BPH, AuNps can inhibit the progression of BPH in a size-dependent manner. while 20 nm AuNps ameliorate BPH by its inhibitory effects on the prostatic cell proliferation, inflammation and angiogenesis, the 50 nm AuNps could potentially exacerbate the development of BPH in rats, mainly through enhancing the inflammatory process. Dove 2019-05-03 /pmc/articles/PMC6507074/ /pubmed/31118628 http://dx.doi.org/10.2147/IJN.S202645 Text en © 2019 Al-Trad et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Al-Trad, Bahaa Aljabali, Alaa Al Zoubi, Mazhar Shehab, Malek Omari, Sahar Effect of gold nanoparticles treatment on the testosterone-induced benign prostatic hyperplasia in rats |
title | Effect of gold nanoparticles treatment on the testosterone-induced benign prostatic hyperplasia in rats |
title_full | Effect of gold nanoparticles treatment on the testosterone-induced benign prostatic hyperplasia in rats |
title_fullStr | Effect of gold nanoparticles treatment on the testosterone-induced benign prostatic hyperplasia in rats |
title_full_unstemmed | Effect of gold nanoparticles treatment on the testosterone-induced benign prostatic hyperplasia in rats |
title_short | Effect of gold nanoparticles treatment on the testosterone-induced benign prostatic hyperplasia in rats |
title_sort | effect of gold nanoparticles treatment on the testosterone-induced benign prostatic hyperplasia in rats |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507074/ https://www.ncbi.nlm.nih.gov/pubmed/31118628 http://dx.doi.org/10.2147/IJN.S202645 |
work_keys_str_mv | AT altradbahaa effectofgoldnanoparticlestreatmentonthetestosteroneinducedbenignprostatichyperplasiainrats AT aljabalialaa effectofgoldnanoparticlestreatmentonthetestosteroneinducedbenignprostatichyperplasiainrats AT alzoubimazhar effectofgoldnanoparticlestreatmentonthetestosteroneinducedbenignprostatichyperplasiainrats AT shehabmalek effectofgoldnanoparticlestreatmentonthetestosteroneinducedbenignprostatichyperplasiainrats AT omarisahar effectofgoldnanoparticlestreatmentonthetestosteroneinducedbenignprostatichyperplasiainrats |